Publications

 

Our 5 most current publications. You can find all Publications at this following link: Pubmed

M. Janning, F. Kobus, A. Babayan, H. Wikman, JL. Velthaus, S. Bergmann, S. Schatz, M. Falk, LA. Berger, LM. Böttcher, S. Päsler, T. Gorges, L. O’Flaherty, C. Hille, S. Joosse, R. Simon, M. Tiemann, C. Bokemeyer, M. Reck, S. Riethdorf, K. Pantel, S. Loges,  Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors. Cancers. 2019 June 17. 

M. Janning, V. Müller,  E. Vettorazzi, M. Cubas-Cordova, V. Gensch, I. Ben-Batalla, C. Zu Eulenburg, C. Schem, PA. Fasching, B. Schnappauf, T. Karn, T. Fehm, M. Jus, T. Kühn, F. Holms, F. Overkamp, P. Krabisch, B. Rack, C. Denkert, M. Untch, H. Tesch, M.  Rezai, K. Kittel, K. Pantel, C. Bokemeyer, S. Loibl, G. von Minckwitz, S. Loges, Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: a biomarker analysis from the GeparQuinto phase III neoadjuvant breast cancer trial. Int J Cancer. 2019 Jan 29. doi: 10.1002/ijc.32163

I. Ben-Batalla, ME. Vargas-Delgado, L. Meier, S. Loges, Sexual dimorphism in solid and hematological malignancies, Semin Immunopathol. 2018 Oct 25. doi: 10.1007/s00281-018-0724-7. 

LA. Berger, M. Janning, JL. Velthaus, I. Ben-Batalla, S. Schatz, M. Falk, P. Iglauer, R. Simon, R. Cao, C. Forcato, N. Manaresi, K. Bramlett, G. Buson, A. Hanssen, M. Tiemann, G. Sauter, C. Bokemeyer, S. Riethdorf, M. Reck, K. Pantel, H. Wikman, S. Loges, Identification of a High-Level MET Amplification in CTCs and cfTNA of an ALK-Positive NSCLC Patient Developing Evasive Resistance to Crizotinib, J Thorac Oncol. 2018 Dec;13(12):e243-e246. 

 

R. Bauer*, F. Udonta*, M. Wroblewski, I. Ben-Batalla, I. Miranda Santos, F. Taverna, M. Kuhlencord, V. Gensch, S. Päsler, S. Vinckier, J. M Brandner, K. Pantel, C. Bokemeyer, T. Vogl, J. Roth, P. Carmeliet, S. Loges, Blockade of myeloid-derived suppressor cell expansion with all-trans retinoic acid increases the efficacy of anti-angiogenic therapy, Cancer Res. 2018 Jun 15;78(12):3220-3232. (* equal contribution)

​​Universitätsklinikum Hamburg-Eppendorf

Campus Forschung (N27)

Personalized Oncology Lab

Prof. Dr. Dr. Sonja Loges

Martinistr. 52
20246 Hamburg

CONTACT

Victoria Gensch
Phone (Lab): +49 (0)40 7410 51992

Phone (Office): +49 (0)40 7410 57420
Fax: +49 (0)40 7410 55896

E-Mail: v.gensch@uke.de

Copyright 2018. Personalized Oncology Lab. - Impressum - Datenschutz